Who owns OUTLOOK THERAPEUTICS INC COM?
- Ticker: OTLK
- CUSIP Number: 69012t305
Tip: Access positions for across all investors
Analyze quarterly positions in Outlook Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Outlook Therapeutics stock
Who bought or sold OUTLOOK THERAPEUTICS INC COM this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| BlackRock | 1.1M | $2.1M | 5% | Dec 2024 |
|
| Vanguard Group | 853k | $1.6M | 0% | Dec 2024 |
|
| Geode Capital Management | 347k | $656k | 2% | Dec 2024 |
|
| UBS Group | 287k | $542k | 3906% | Dec 2024 |
|
| State Street Corporation | 249k | $470k | 7% | Dec 2024 |
|
| Tang Capital Management | 183k | $345k | -88% | Dec 2024 |
|
| FMR | 182k | $343k | 15192% | Dec 2024 |
|
| Woodline Partners | 152k | $286k | 0% | Dec 2024 |
|
| Renaissance Technologies | 130k | $246k | 100% | Dec 2024 |
|
| Northern Trust | 112k | $211k | -6% | Dec 2024 |
|
| Susquehanna International | 103k | $194k | 91% | Dec 2024 |
|
| GSA Capital Partners | 100k | $190k | 100% | Dec 2024 |
|
| Scotia Capital | 74k | $140k | 124% | Dec 2024 |
|
| Goldman Sachs Group | 60k | $112k | 67% | Dec 2024 |
|
| AQR Capital Management | 59k | $112k | 100% | Dec 2024 |
|
| Morgan Stanley | 57k | $109k | 31% | Dec 2024 |
|
| Citadel Advisors | 43k | $81k | -43% | Dec 2024 |
|
| Charles Schwab Investment Management | 36k | $68k | -30% | Dec 2024 |
|
| Bank of New York Mellon | 30k | $56k | 45% | Dec 2024 |
|
| Jane Street | 26k | $50k | 134% | Dec 2024 |
|
| Commonwealth Equity Services | 26k | $48k | 100% | Dec 2024 |
|
| Barclays | 24k | $45k | 14% | Dec 2024 |
|
| Bank of America Corporation | 19k | $37k | 28% | Dec 2024 |
|
| Russell Investments | 17k | $32k | 34937% | Dec 2024 |
|
| Rhumbline Advisers | 16k | $20k | -91% | Mar 2025 |
|
| Citigroup | 15k | $28k | 22% | Dec 2024 |
|
| Qube Research & Technologies | 14k | $26k | 100% | Dec 2024 |
|
| JustInvest | 12k | $23k | 100% | Dec 2024 |
|
| Two Sigma Investments | 11k | $20k | 100% | Dec 2024 |
|
| Christensen, King & Associates Investment Services | 11k | $16k | 3% | Dec 2024 |
|
| XTX Topco | 10k | $19k | -73% | Dec 2024 |
|
| Fifth Third Wealth Advisors | 10k | $12k | 0% | Mar 2025 |
|
| Pnc Financial Services | 10k | $19k | 0% | Dec 2024 |
|
| Wells Fargo & Company | 9.3k | $19k | 67% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 8.7k | $16k | 5% | Dec 2024 |
|
| Corebridge Financial | 7.6k | $14k | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 7.5k | $14k | 5% | Dec 2024 |
|
| Tower Research Capital | 6.4k | $12k | 228% | Dec 2024 |
|
| Advisor Group Holdings | 3.4k | $18k | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 3.0k | $5.6k | -2% | Dec 2024 |
|
| Riggs Asset Managment | 2.5k | $4.7k | 100% | Dec 2024 |
|
| Northwestern Mutual Wealth Management Company | 2.1k | $4.0k | 0% | Dec 2024 |
|
| New York State Common Retirement Fund | 1.8k | $3.0k | 0% | Dec 2024 |
|
| Legal & General Group | 1.6k | $3.0k | 0% | Dec 2024 |
|
| Royal Bank of Canada | 1.4k | $0 | -45% | Dec 2024 |
|
| California State Teachers Retirement System | 1.1k | $2.1k | 0% | Dec 2024 |
|
| Ancora Advisors | 1.1k | $2.1k | -82% | Dec 2024 |
|
| CWM | 877.00 | $2.0k | 107% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 706.00 | $1.3k | -90% | Dec 2024 |
|
| Summit Investment Advisors | 607.00 | $1.1k | 0% | Dec 2024 |
|
| Federated Investors | 477.00 | $902.007000 | -99% | Dec 2024 |
|
| Harbour Investments | 227.00 | $429.007300 | 79% | Dec 2024 |
|
| SBI Securities | 210.00 | $397.005000 | 100% | Dec 2024 |
|
| Sterling Capital Management | 206.00 | $388.989800 | 1273% | Dec 2024 |
|
| EverSource Wealth Advisors | 188.00 | $355.000400 | 100% | Dec 2024 |
|
| Armstrong Advisory Group | 179.00 | $339.008100 | 0% | Mar 2025 |
|
| Amalgamated Bank | 153.00 | $0 | 0% | Dec 2024 |
|
| Larson Financial Group | 100.00 | $189.000000 | 0% | Dec 2024 |
|
| Prestige Wealth Management Group | 62.00 | $117.998400 | 0% | Dec 2024 |
|
| Steward Partners Investment Advisory | 14.00 | $25.999400 | 0% | Dec 2024 |
|
| IFP Advisors | 3.00 | $6.000000 | 100% | Dec 2024 |
|
Who sold out of Outlook Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Dr. Jeffrey R. Jay, M.D. | Sep 2024 | 1.3M | $6.9M |
| Altium Capital Management | Sep 2024 | 542k | $2.9M |
| Sphera Funds Management | Sep 2024 | 414k | $2.2M |
| Caligan Partners | Sep 2024 | 319k | $1.7M |
| Schonfeld Strategic Advisors | Sep 2024 | 286k | $1.5M |
| Boothbay Fund Management | Sep 2024 | 159k | $851k |
| Caption Management | Sep 2024 | 144k | $768k |
| Corton Capital | Sep 2024 | 31k | $166k |
| Nuveen Asset Management | Sep 2024 | 20k | $107k |
| LPL Financial | Sep 2024 | 12k | $62k |
| ExodusPoint Capital Management | Sep 2024 | 11k | $60k |
| Gables Capital Management | Sep 2024 | 11k | $59k |
| Brian McDonald | Sep 2024 | 488.00 | $2.6k |
| NISA Investment Advisors | Sep 2024 | 15.00 | $79.999500 |